Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 9—September 2020
Research Letter

Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March–April 2020

Avnish Sandhu, Glenn Tillotson, Jordan Polistico, Hossein Salimnia, Mara Cranis, Judy Moshos, Lori Cullen, Lavina Jabbo, Lawrence Diebel, and Teena ChopraComments to Author 
Author affiliations: Detroit Medical Center, Detroit, Michigan, USA (A. Sandhu, J. Polistico, H. Salimnia, M. Cranis, J. Moshos, L. Cullen, L. Jabbo, T. Chopra); Wayne State University School of Medicine, Detroit (A. Sandhu, J. Polistico, H. Salimnia, L. Diebel, T. Chopra); GST Micro LLC, Henrico, Virginia, USA (G. Tillotson)

Main Article


Baseline demographic and clinical characteristics of 9 patients with Clostridioides difficile and severe acute respiratory syndrome coronavirus 2 co-infection, Detroit, Michigan, USA, March–April 2020*

Characteristic Value
Age, y, median
F 7
African American 6
Caucasian 1
Hospitalization in prior 60 d 5
Required intensive care unit and vasopressors
ATLAS score, median† 6
Charlson comorbidity index score, median
Symptoms at admission
Cough 4
Shortness of breath 3
Fever 4
Diarrhea and abdominal pain
Laboratory results
Ferritin, ng/mL, median‡ 1,459.4
Leukocyte count, x 103 cells/mm3), average 12.0
Creatinine, mg/dL, average§
Microbiologic findings
Blood culture positive 2
Respiratory culture positive 2

*Values indicate no. patients unless otherwise indicated. Some patients had >1 symptom.
†Scoring information available at
‡Ferritin was only obtained in 8 patients.
§Three patients were on dialysis.

Main Article

Page created: May 20, 2020
Page updated: August 20, 2020
Page reviewed: August 20, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.